CXCL1, C-X-C motif chemokine ligand 1, 2919

N. diseases: 315; N. variants: 3
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0001339
Disease: Acute pancreatitis
Acute pancreatitis
0.010 AlteredExpression disease BEFREE Concordantly, expression of AP-induced STAT3-responsive chemokines, especially monocyte chemotactic protein-1 (MCP-1) and chemokine (C-X-C motif) ligand 1 (CXCL1) was reduced, thereby contributing to modulated pancreatic immune milieu. 31726046 2020
CUI: C0014544
Disease: Epilepsy
Epilepsy
0.010 Biomarker disease BEFREE Endothelial Cdk5 deficit leads to the development of spontaneous epilepsy through CXCL1/CXCR2-mediated reactive astrogliosis. 31699822 2020
CUI: C1258215
Disease: Ileus
Ileus
0.010 Biomarker disease BEFREE CXCL1 is a potential target for preventing or treating ileus in trauma patients. 31722447 2020
Intestinal obstruction co-occurrent and due to decreased peristalsis
0.010 Biomarker disease BEFREE CXCL1 is a potential target for preventing or treating ileus in trauma patients. 31722447 2020
CUI: C0007785
Disease: Cerebral Infarction
Cerebral Infarction
0.010 AlteredExpression disease BEFREE Infarct volume was quantified at 48 h. Data showed that BET degradation significantly reduced infarct volume in permanent focal cerebral ischemia in aged mice, and this was associated with reduced brain levels of pro-inflammatory mediators including TNF-α, CXCL1, CXCL10, CCL2, and matrix metalloproteinase-9. 30872008 2019
CUI: C0010692
Disease: Cystitis
Cystitis
0.010 Biomarker disease BEFREE Urinary markers that best differentiated pyelonephritis from cystitis included chemokine (C-X-C motif) ligand (CXCL)1, CXCL9, CXCL12, C-C motif chemokine ligand 2, INF γ, and IL-15. 30905425 2019
CUI: C0011847
Disease: Diabetes
Diabetes
0.010 AlteredExpression disease BEFREE On the other hand, although diabetes inhibits formalin-induced nociception higher protein levels of pro-inflammatory cytokine IL1-β and chemokine CINC-1/CXCL-1 were observed. 31404587 2019
CUI: C0011849
Disease: Diabetes Mellitus
Diabetes Mellitus
0.010 AlteredExpression group BEFREE On the other hand, although diabetes inhibits formalin-induced nociception higher protein levels of pro-inflammatory cytokine IL1-β and chemokine CINC-1/CXCL-1 were observed. 31404587 2019
CUI: C0015695
Disease: Fatty Liver
Fatty Liver
0.010 AlteredExpression disease BEFREE Hepatic expression of C-X-C motif chemokine ligand 1 (CXCL1), a key chemokine for neutrophil infiltration (a hallmark of NASH), is highly elevated in NASH patients but not in fatty livers in obese individuals or in high-fat diet (HFD)-fed mice. 31705800 2019
CUI: C0015967
Disease: Fever
Fever
0.010 AlteredExpression phenotype BEFREE Bone marrow progenitor cell colony-forming unit (CFU) count, serum cytokine levels, and peripheral leukocyte count after HIPEC and IP chemotherapy were compared.<b>Results:</b> Peripheral neutrophil count, cytokine (G-CSF and CXCL1/KC) levels, and bone marrow progenitor cell CFU count were significantly higher after HIPEC than after IP chemotherapy.<b>Conclusions:</b> Hyperthermia increased the serum neutrophil-recruiting cytokine levels and reduced the magnitude of chemotherapy-induced neutropenia. 31818168 2019
CUI: C0020541
Disease: Portal Hypertension
Portal Hypertension
0.010 AlteredExpression disease BEFREE Mechanical Stretch Increases Expression of CXCL1 in Liver Sinusoidal Endothelial Cells to Recruit Neutrophils, Generate Sinusoidal Microthombi, and Promote Portal Hypertension. 30872106 2019
CUI: C0021400
Disease: Influenza
Influenza
0.010 AlteredExpression disease BEFREE Our findings support the conclusion that selective suppression of CXCL1/CXCL2 represents an IFN-β-mediated "training" of the macrophage transcriptional response to TLR2 agonists and that blocking of TLR4 therapeutically with Eritoran after influenza virus infection reverses this suppression by blunting influenza-induced IFN-β. 31064834 2019
CUI: C0031117
Disease: Peripheral Neuropathy
Peripheral Neuropathy
0.010 Biomarker group BEFREE Spinal blockage of CXCL1 and its receptor CXCR2 inhibits paclitaxel-induced peripheral neuropathy in mice. 30991054 2019
CUI: C0033578
Disease: Prostatic Neoplasms
Prostatic Neoplasms
0.010 Biomarker group BEFREE <b>Principal conclusions</b>: Taken together, our results argue that CXCL1 plays an important role in sustaining the growth of bladder and prostate tumors via up-regulation of IL6 and down-regulation of TIMP4. 30809313 2019
CUI: C0034186
Disease: Pyelonephritis
Pyelonephritis
0.010 Biomarker disease BEFREE Urinary markers that best differentiated pyelonephritis from cystitis included chemokine (C-X-C motif) ligand (CXCL)1, CXCL9, CXCL12, C-C motif chemokine ligand 2, INF γ, and IL-15. 30905425 2019
CUI: C0039263
Disease: Takayasu Arteritis
Takayasu Arteritis
0.010 Biomarker disease BEFREE Considering this, we further built a logistic regression model based on multiple cytokines, including CA (cancer antigen) 125, FLRG (follistatin-related protein), IGFBP (insulin-like growth factor-binding protein)-2, CA15-3, GROa (growth-regulated alpha protein), LYVE (lymphatic vessel endothelial hyaluronic acid receptor)-1, ULBP (UL16-binding protein)-2, and CD (cluster of differentiation) 99, with an area under the curve reaching 0.909 for discriminating TA activity status. 30645172 2019
CUI: C0040034
Disease: Thrombocytopenia
Thrombocytopenia
0.010 Biomarker phenotype BEFREE PLAG significantly decreased plasma levels of the chemokine (C-X-C motif) ligand 1 (CXCL1), CXCL2, interleukin (IL)-6, and C-reactive protein (CRP), which were elevated consistently with the occurrence time of neutropenia, monocytopenia, and thrombocytopenia. 31752148 2019
CUI: C0150055
Disease: Chronic pain
Chronic pain
0.010 Biomarker phenotype BEFREE CXCL1 chemokine and its receptor CXCR2 have been pointed as promising targets to treat chronic pain. 30991054 2019
CUI: C0154830
Disease: Proliferative diabetic retinopathy
Proliferative diabetic retinopathy
0.010 Biomarker disease BEFREE CXCL1 concentration was measured in vitreous fluid samples obtained from proliferative diabetic retinopathy (PDR) and nondiabetic control eyes. 31652327 2019
CUI: C0275524
Disease: Coinfection
Coinfection
0.010 Biomarker phenotype BEFREE Knockdown of IL-17C significantly reduced induction of CXCL1 in response to HRV-bacterial coinfection as well as neutrophil chemotaxis. 30504421 2019
CUI: C0394005
Disease: Ataxic cerebral palsy
Ataxic cerebral palsy
0.010 Biomarker disease BEFREE For neutrophil chemotactic factor, significant increases of IL-8 and GRO were observed in ACP, but for eosinophil chemotactic factor, no difference was found in RANTES and GM-CSF. 31249603 2019
CUI: C0431129
Disease: Adamantinous Craniopharyngioma
Adamantinous Craniopharyngioma
0.010 Biomarker disease BEFREE For neutrophil chemotactic factor, significant increases of IL-8 and GRO were observed in ACP, but for eosinophil chemotactic factor, no difference was found in RANTES and GM-CSF. 31249603 2019
CUI: C0432283
Disease: Osteoglophonic dwarfism
Osteoglophonic dwarfism
0.010 AlteredExpression disease BEFREE Additionally, upregulation of CXCL1 and promoted inflammatory response was also found in MCAO rats. miR-181c-3p was downregulated in OGD-treated cortical neurons and exosomes derived from OGD-treated cortical neurons. 31665717 2019
CUI: C0600041
Disease: Infective cystitis
Infective cystitis
0.010 Biomarker disease BEFREE Urinary markers that best differentiated pyelonephritis from cystitis included chemokine (C-X-C motif) ligand (CXCL)1, CXCL9, CXCL12, C-C motif chemokine ligand 2, INF γ, and IL-15. 30905425 2019
CUI: C0740391
Disease: Middle Cerebral Artery Occlusion
Middle Cerebral Artery Occlusion
0.010 AlteredExpression disease BEFREE Additionally, upregulation of CXCL1 and promoted inflammatory response was also found in MCAO rats. miR-181c-3p was downregulated in OGD-treated cortical neurons and exosomes derived from OGD-treated cortical neurons. 31665717 2019